Skip to main content

Kaveri Pohlman

Stock Analyst at BTIG

Total Price Targets
6
Stocks Covered
5
Sectors
Healthcare
Most Recent
May 23, 2024

Stocks Covered by Kaveri Pohlman

SymbolCompanyLatest TargetCurrent PriceUpside# TargetsLast Updated
MGNXMacroGenics, Inc.$9.00$3.16+184.8%2May 23, 2024
CGEMCullinan Therapeutics, Inc.$30.00$13.48+122.5%1Apr 17, 2024
XNCRXencor, Inc.$38.00$12.88+195.1%1Apr 16, 2024
NUVBNuvation Bio Inc.$5.00$4.50+11.2%1Mar 26, 2024
JANXJanux Therapeutics, Inc.$62.00$14.35+332.2%1Mar 20, 2024

Recent Activity

  • May 23, 2024— Set$9.00price target onMGNX(MacroGenics, Inc.)
  • Apr 17, 2024— Set$30.00price target onCGEM(Cullinan Therapeutics, Inc.)
  • Apr 16, 2024— Set$38.00price target onXNCR(Xencor, Inc.)
  • Mar 26, 2024— Set$5.00price target onNUVB(Nuvation Bio Inc.)
  • Mar 20, 2024— Set$62.00price target onJANX(Janux Therapeutics, Inc.)
  • Jul 11, 2022— Set$6.00price target onMGNX(MacroGenics, Inc.)

Frequently Asked Questions

Who is Kaveri Pohlman?

Kaveri Pohlman is a stock analyst at BTIG covering 5 stocks primarily in Healthcare. They have issued 6 price targets since Jul 11, 2022.

What stocks does Kaveri Pohlman cover?

Kaveri Pohlman currently covers 5 stocks, including MGNX, CGEM, XNCR, NUVB, JANX.

What is Kaveri Pohlman's latest price target?

Kaveri Pohlman's most recent price target was $9.00 on MGNX (MacroGenics, Inc.), set on May 23, 2024.

What is Kaveri Pohlman's highest price target?

Kaveri Pohlman's highest issued price target is $62.00 on JANX, set on Mar 20, 2024.

Coverage based on publicly published price targets. Not investment advice.